You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
|
|---|---|
| Published in |
Arthritis Research & Therapy, October 2013
|
| DOI | 10.1186/ar4359 |
| Pubmed ID | |
| Authors |
Francesco Carubbi, Paola Cipriani, Alessandra Marrelli, Paola Di Benedetto, Piero Ruscitti, Onorina Berardicurti, Ilenia Pantano, Vasiliki Liakouli, Saverio Alvaro, Alessia Alunno, Antonio Manzo, Francesco Ciccia, Roberto Gerli, Giovanni Triolo, Roberto Giacomelli |
| Abstract |
Primary Sjögren's syndrome (pSS) is an autoimmune disorder affecting exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular involvement leading to a worsening of disease prognosis. Current therapeutic options are mainly empiric and often translated by other autoimmune diseases. In the last few years growing evidence suggests that B-cell depletion by rituximab (RTX) is effective also in pSS. Patients with early active disease appear to be those who could benefit the most from RTX. The aim of this study was to investigate the efficacy and safety of RTX in comparison to disease modifying anti-rheumatic drugs (DMARDs) in early active pSS patients. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 4 | 31% |
| United States | 2 | 15% |
| India | 1 | 8% |
| Ecuador | 1 | 8% |
| United Kingdom | 1 | 8% |
| South Africa | 1 | 8% |
| Bulgaria | 1 | 8% |
| Unknown | 2 | 15% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 62% |
| Practitioners (doctors, other healthcare professionals) | 3 | 23% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Switzerland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 119 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 19% |
| Researcher | 14 | 11% |
| Student > Master | 14 | 11% |
| Student > Bachelor | 13 | 10% |
| Other | 13 | 10% |
| Other | 25 | 20% |
| Unknown | 21 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 49% |
| Agricultural and Biological Sciences | 10 | 8% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Immunology and Microbiology | 3 | 2% |
| Psychology | 3 | 2% |
| Other | 11 | 9% |
| Unknown | 31 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#4,535,680
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#988
of 3,380 outputs
Outputs of similar age
#39,758
of 225,515 outputs
Outputs of similar age from Arthritis Research & Therapy
#15
of 65 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,380 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.